Conditional deletion of KIF2A at the third postnatal week, using a tamoxifen-inducible mouse (CAGG-Cre-ERTM;Kif2aF/F), also triggers epilepsy (Homma et al., 2018). Here, KIF2A is linked to epilepsy.